GREEN SYNTHESIS OF SILVER NANOPARTICLES (AgNPs) USING HELVELLA LEUCOPUS PERS. AND THEIR ANTIMYCOTIC ACTIVITY AGAINST FUNGI CAUSING FUNGAL ROT OF APPLE
Objectives: The main objective of the present study was to synthesize silver nanoparticles (AgNPs) by green approach using Helvella leucopus and to evaluate the antimycotic activity of synthesized AgNPs against fungi causing fungal rot of apple.
Methods: During the present study for green synthesis of AgNPs using H. leucopus, equal volumes of both mushroom extract (100 ml) and silver nitrate solution (100 ml) were mixed and incubated at room temperature for the bioreduction process. These synthesized AgNPs were characterized by ultraviolet–visible spectroscopy, scanning electron microscopy, Fourier transmission infrared spectroscopy, and X-ray diffraction analysis. Furthermore, these synthesized AgNPs were evaluated for their antimycotic activity by spore germination method and agar well diffusion assay against different tested fungi.
Results: The results revealed that strong plasmon absorbance band was observed at 420 nm which confirms the synthesis of AgNPs using H. leucopus. The synthesized AgNPs were spherical in aggregated form with size ranging from 80 to 100 nm. Furthermore, different concentrations of synthesized AgNPs caused significant inhibition in spore germination and reduction in zone of inhibition of tested fungal pathogens. The highest inhibition in spore germination by AgNPs at highest concentrations was observed against Penicillium chrysogenum followed by Aspergillus niger and Alternaria alternata, respectively. Similarly, the synthesized AgNPs at highest concentrations showed maximum zone of inhibition against P. chrysogenum followed by A. niger and A. alternata, respectively.
Conclusion: It is concluded from the present study that synthesized AgNPs have good potential to be used as antifungal agents against many fungal plant pathogens. The synthesized AgNPs using mushroom fungi also have potential for the development of nanofungicides against fungal pathogens but after proper investigation.
2. Malik MA, Brien PO, Revaprasadu NA. Simple route to the synthesis of core/shell nanoparticles of chalcogenides. Chem Mater 2002;14:2004-10.
3. Shah M, Fawcett D, Sharma S, Tripathy SK, Poinern GE. Green synthesis of metallic nanoparticles via biological entities. Materials 2015;8:7278-308.
4. Parveen S, Wani AH, Shah MA, Devi HS, Bhat MY, Koka JA. Preparation, characterization and antifungal activity of iron oxide nanoparticles. Microb Pathog 2018;115:287-92.
5. Thakkar KN, Mhatre SS, Parikh RY. Biological synthesis of metallic nanoparticles. Nanomedicine 2010;6:257-62.
6. Parikh RY, Singh S, Prasad BL, Patole MS, Sastry M, Shouche YS. Extracellular synthesis of crystalline silver nanoparticles and molecular evidence of silver resistance from Morganella sp. towards understanding biochemical synthesis mechanism. Chembiochem 2008;9:1415-22.
7. Griffiths E. Iatrogenic plant diseases. Ann Revis Phytopathol 1981;19:69-82.
8. Spotts RA, Cervantes LA. Population, pathogenicity and benomyl resistance of Botrytis spp. Penicillium spp. and Mucor piriformis in packinghouses. Plant Dis 1986;70:106-8.
9. Parveen S, Wani AH, Bhat MY, Pala SA, Ganie AA. Biology and management of Aspergillus Niger Van Tiegh. Causing black mold rot of pear (Pyrus communis L.) in Kashmir valley India. Int J Adv Res 2014;2:24-34.
10. Abdullah Q, Mahmoud A, Al-Harethi A. Isolation and identification of fungal postharvest rot of some fruits in Yemen PSM. Microbiology 2016;1:36-44.
11. Raghupati RK, Koodali RT, Manna AC. Size-dependent bacterial growth inhibition and mechanism of antibacterial activity of zinc oxide nanoparticles. Langmuir 2011;27:4020-8.
12. Kim SW, Jung JH, Lamsal K, Kim YS, Min JS, Lee YS. Antifungal effects of silver nanoparticles (AgNPs) against various plant pathogenic fungi. Mycobiology 2012;40:53-8.
13. Philip D. Biosynthesis of Au, Ag and Au-Ag nanoparticles using edible mushroom extract. Spectrochem Acta A Mol Biomol Spectrosc 2009;73:374-81.
14. Nithya R, Ragunathan R. Synthesis of silver nanoparticle using Pleurotus sajor caju and its antimicrobial study. Dig J Nanomater Biostruct 2009;4:623-9.
15. Karwa A, Gaikwad S, Rai M. Mycosynthesis of silver nanoparticles using lingzhi or reishi medicinal mushroom Ganoderma lucidum (W. Curt. Fr) Karst and their role as antimicrobials and antibiotic enhancers. Int J Med Mushrooms 2011;13:483-91.
16. Balahanmugam P, Santhosh S, Giyaullah H, Balakumaran MD, Kalaichelvan PT. Mycosynthesis, characterisation and antibacterial activity of silver nanoparticles from Microsporus xanthopus. A macro mushroom. Int J Innov Res Sci Eng Technol 2013;2:6262-70.
17. Haq M, Rathod V, Shivraj N, Singh D, Yasin M, Singh AK. Silver nanoparticles from mushroom Agricus bisporus and their activity against multi drug resistant strains of Klebsiella spp. Pseudomonas sp. and Acinetobacter sp. Int J Nat Prod Res 2015;5:20-6.
18. Tian J, Wong KK, Ho CM, Lok CN, Yu WY, Che CM, et al. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem 2007;2:129-36.
19. Stensberg MC, Wei Q, Mclamore ES, Porterfield DM, Wei A, Sepulveda MS. Toxicological studies on silver nanoparticles: Challenges and opportunities in assessment, monitoring and imaging. Nanomedicine 2011;6:879-98.
20. Kulkarni N, Maddapur U. Biosynthesis of metal nanoparticles. A review. J Nanotechnol 2014;2014:1-8.
21. Kumar A, Bhatt RP, Lakhanpal TN. In: Singh B, Singh MP, editors. The Amanitaceae of India. Dheradun, India: Bishen Singh Mahendra Pal Singh; 1990.
22. Atri NS, Kaur A, Kaur H. Wild mushrooms collection and identification. Mushroom Res 2003;14:56-9.
23. Narasimha G, Praveen BK, Mallikarjuna KB, Raju DP. Mushrooms (Agaricus bisporus) mediated biosynthesis of sliver nanoparticles. Characterization and their antimicrobial activity. Int J Nano Dim 2011;2:29-36.
24. Kiraly Z, Klement Z, Solymosy F, Voros J. Methods in Plant Pathology with Special Reference to Breeding for Resistance. New York: Elsevier Publishing Company; 1974.
25. Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 2008;3:163-75.
26. Norrel SA, Messley KE. Microbiology Laboratory Manual Principles and Applications. New Jersey: Prentice Hall Upper Saddle River; 1997. p. 85-90.
27. Sudhakar T, Nanda A, Babu SG, Janani S, Evans MD, Markose TK. Synthesis of silver nanoparticles from edible mushroom and its antimicrobial activity against human pathogens. Int J Pharm Tech Res 2014;5:1718-23.
28. Patil S, Sivaraj R, Rajiv P, Venckatesh R, Seenivasan R. Green synthesis of silver nanoparticle from leaf extract of Aegle marmelos and evaluation of its antibacterial activity. Int J Pharm Pharm Sci 2015;7:169-73.
29. Murugesa S, Bhuvaneswari S, Sivamurugan V. Green synthesis, characterization of silver nanoparticles of a marine red alga Spyridia fusiformis and their antibacterial activity. Int J Pharm Pharm Sci 2017;9:192-7.
30. Janakiraman M. Protective efficacy of silver nanoparticles synthesized from silymarin on cisplatin induced renal oxidative stress in albino rat. Int J Appl Pharm 2018;10:110-6.
31. Chandrappa CP, Chandrasekar N, Govindappa M, Shanbhag C, Singh UK, Masarghal J. Antibacterial activity of synthesized silver nanoparticles by Simarouba glauca against pathogenic Bacteria. Int J Curr Pharm Res 2017;9:19-22.
32. Rajeshkumar S, Malarkodi C, Kumar VS. Synthesis and characterization of silver nanoparticles from marine brown seaweed and its antifungal efficiency against clinical fungal pathogens. Asian J Pharm Clin Res 2017;10:190-3.
33. Pulit J, Banach M, Szczyglowska R, Bryk M. Nanosilver against fungi. Silver nanoparticles as an effective biocidal factor. Acta Biochim Pol 2013;60:795-8.
34. Ray S, Sarkar S, Kundu S. Extracellular biosynthesis of silver nanoparticles using the mycorrhizal mushroom Tricholoma crassum (Berk.) Sacc: Its antimicrobial activity against pathogenic Bacteria and fungus, including multidrug resistant plant and human bacteria. Dig J Nanomater Bios 2011;6:1289-99.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.